Consensus on managing delayed methotrexate elimination in high-dose therapy: insights from the Middle East
{{output}}
Introduction: High-dose methotrexate (HDMTX) therapy is a cornerstone in treating pediatric and adult cancers, namely, acute lymphoblastic leukemia, non-Hodgkin lymphoma, and osteosarcoma, due to its capability to penetrate the b... ...
